Clareo Health | Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dattoli Cancer Center and Brachytherapy Research Institute
With
Sanofi
Age
45–80
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Males age 45-80 years
Diagnosis of prostate cancer
Status post IMRT and Palladium-103 seed implantation and initiated alpha blocker therapy with alfuzosin10mg daily or tamulosin 0.4mg bid at time of seed implantation
Baseline AUA score\< or =12
May be on antiandrogenand/or alpha reductase therapy
Patients receiving IMRT followed by Palladium-103 Brachytherapy implantation as the primary therapy for prostate cancer with curatives intent -
You may not be if
History of insulin-dependent diabetes
Uncontrolled hypertention
History of symptomtic hypotension (including syncope and dizziness)
Pre-existing obstructive uropathy based on history of BPH and or Acute Urinary Retention
Pre-existing prostatitis either continuous or intermittent
